Braveheart Investment Group PLC - Dodworth, England-based investment company - Announces conditional sale of Phasefocus Holdings Ltd to analytics instrumentation company Bruker UK Ltd for £5 million. Once closing conditions are satisfied, Braveheart expects completion of the sale to occur in the first quarter of 2024. Consideration will be payable in cash and represent £17.74 per Phasefocus share. Braveheart currently holds 48.3% of Phasefocus’s issued share capital. Estimates that it will receive total sale proceeds of approximately £2.1 million after expenses. Braveheart says board is still considering whether to use proceeds to continue support further investments in technology-based companies, or whether to redistribute the proceeds via a special dividend.

Current stock price: 8.68 pence, up 2.1%

12-month change: down 11%

Copyright 2023 Alliance News Ltd. All Rights Reserved.